I-3-Indolepropionic Acid (IPA) CAS 830-96-6 Ubunyulu > 99.5% (HPLC) Factory High Quality

Inkcazelo emfutshane:

Igama leMchiza: 3-Indolepropionic Acid (IPA)

CAS: 830-96-6

Ubunyulu: >99.5% (HPLC)

Imbonakalo: Okumhlophe-Kumhlophe ukuya kumgubo oMthubi oKhanyayo okanye iiCrystals

Umgangatho ophezulu, iMveliso yoRhwebo

E-Mail: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili kunye nomthengisi we-3-Indolepropionic Acid (IPA) (i-CAS: 830-96-6) enomgangatho ophezulu, imveliso yorhwebo.Wamkelekile kwiodolo.

Iipropati zeMichiza:

Igama leMchiza	I-3-Indolepropionic Acid
Izithethantonye	IPA;I-3-(1H-indol-3-yl) ipropanoic acid;3-(1H-indol-3-yl) -propionic acid;3-(3-Indolyl) propanoic acid;3-(3-Indolyl) propionic acid
Inombolo yeCAS	830-96-6
Inombolo yeCAT	RF-PI1540
Ubume beStokhwe	Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli	C11H11NO2
Ubunzima beMolekyuli	189.21
Ukunyibilika kwiMethanol	I-Turbidity eFaint kakhulu
Indawo yokubilisa	82℃ (lit.)
Ukuxinana	0.960 g/mL ku-20℃
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	I-Off-White ukuya kwiPowder emthubi eKhanyayo okanye iiCrystals
Ubunyulu / Indlela yokuHlalutya	>99.5% (HPLC)
Indawo yokunyibilika	130.0 ~ 136.0℃
Ukufuma (nguKarl Fischer)	<0.50%
Ukungacoceki Okukodwa	<0.50%
Ukungcola ngokupheleleyo	<0.50%
I-1 H NMR Spectrum	Ukungqinelana Nolwakhiwo
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	AbaPhakathi bamayeza

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.

Izinto eziluncedo:

FAQ:

Isicelo:

I-3-Indolepropionic Acid (IPA) (i-CAS: 830-96-6), I-Reactant ukulungiselela: I-Fluorescent analogues ye-strigolactones;ii-Anti-tumor agents;Melanocortin receptors ligands;i-immunosuppressive agents;Iihibitors zentsholongwane ye-hepatitis C;I-Histamine H4 i-receptor agonists;I-NR2B/NMDA abachasi be-receptor;Umchasi we-CB1 wonyango lokutyeba;ii-antibacterial agents;Inhibitor ye-TGF-β yokubopha i-receptor.